YungShin Global Holding Corporation (TPE:3705)

Market Cap	15.29B
Revenue (ttm)	8.56B
Net Income (ttm)	986.30M
Shares Out	266.36M
EPS (ttm)	3.70
PE Ratio	15.51
Forward PE	n/a
Dividend	3.00 (5.23%)
Ex-Dividend Date	Jun 24, 2025

Volume	1,497,832
Average Volume	646,558
Open	58.30
Previous Close	57.40
Day's Range	57.50 - 59.00
52-Week Range	51.90 - 69.90
Beta	0.11
RSI	65.97
Earnings Date	Sep 11, 2025

About YungShin Global Holding

YungShin Global Holding Corporation, through its subsidiaries, invests in, manufactures, and sells medicines, animal drugs, agricultural chemicals, industrial medicines, and cosmetics. The company is also involved in trade, investment, and other related businesses; import and export trading; and sale of medicine. It has operations in Taiwan, the United States, Mainland China, and Japan. The company was incorporated in 2011 and is headquartered in Taipei City, Taiwan.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 2011
• Country: Taiwan
• Stock Exchange: Taiwan Stock Exchange
• Ticker Symbol: 3705

Financial Performance

In 2024, YungShin Global Holding's revenue was 8.03 billion, an increase of 14.29% compared to the previous year's 7.03 billion. Earnings were 1.17 billion, an increase of 41.24%.